Swedish Orphan Biovitrum AB
SOBI
ISIN SE0000872095 / Valor 2676862
Swedish Orphan Biovitrum AB
UMushroom community rating:
About company
Swedish Orphan Biovitrum AB (Sobi) is a global biopharmaceutical company focused on developing and commercializing innovative therapies for rare and serious diseases. Sobi specializes in areas such as hematology, immunology, and gene therapy, addressing unmet medical needs in conditions like hemophilia, immune deficiencies, and other rare disorders. The company operates internationally, leveraging its expertise in biotechnology to bring effective treatments to patients worldwide. Sobi collaborates with healthcare professionals, research institutions, and industry partners to advance its drug pipeline and expand access to its medications, aiming to improve patient outcomes and enhance quality of life for those affected by debilitating diseases.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
15470 M
Market cap (USD)
314,038
Daily traded volume (Shares)
317.8 / 311.8
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
